Charles Schwab director sold shares under 10b5-1 plan at ~$96.64
Rhea-AI Filing Summary
Carolyn Schwab-Pomerantz, a director of The Charles Schwab Corporation (SCHW), reported multiple dispositions of Common Stock on 09/04/2025 executed under a Rule 10b5-1 trading plan adopted on August 14, 2024. The filing shows sales of 14,400 shares (reported at a weighted-average price of $96.6377) and 9,600 shares (weighted-average $96.6372), with the transactions executed in multiple trades at prices ranging from $96.235 to $96.93. Following the reported transactions, the filing discloses beneficial ownership positions including 1,449,256.6599 shares held indirectly by a trust and 450,514 shares held indirectly by a spouse as trustee. The Form 4 was signed by an attorney-in-fact on 09/05/2025.
Positive
- Sales executed under a Rule 10b5-1 plan, adopted August 14, 2024, which supports pre-arranged compliance with insider trading rules
- Detailed execution transparency: weighted-average prices and trade price ranges are disclosed
- Significant retained ownership is reported (e.g., 1,449,256.6599 shares indirectly by trust and 450,514 indirectly by spouse as trustee)
Negative
- Dispositions of shares: 14,400 and 9,600 shares were reported sold on 09/04/2025
- Multiple trades were executed across a price range ($96.235 to $96.93), which may complicate precise per-trade analysis
Insights
TL;DR: Routine insider sales under a 10b5-1 plan; transactions were executed across multiple trades at near-$96.6 prices.
The sales reported are dispositions, not exercises or derivative events, and were executed pursuant to a pre-established Rule 10b5-1 plan adopted in August 2024, which typically indicates pre-planned sales rather than opportunistic trading. The weighted-average prices ($96.6377 and $96.6372) and disclosed price ranges provide transparency on execution. The reporting person retains substantial indirect holdings (over 1.4 million shares by trust and ~450k by spouse as trustee), suggesting continued significant economic interest in SCHW.
TL;DR: Governance practices observed: use of 10b5-1 plan and attorney-in-fact signature; disclosure appears complete for the transactions listed.
The filing identifies the reporting person as a director and indicates the trades were made pursuant to a Rule 10b5-1 plan, which supports compliance with insider trading policies. The filing includes weighted-average prices, price ranges, and the plan adoption date, and it is signed by an authorized attorney-in-fact, meeting common disclosure standards. No amendments or indications of unusual trading mechanics are present in the provided content.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 14,400 | $96.6377 | $1.39M |
| Sale | Common Stock | 9,600 | $96.6372 | $928K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024. This transaction was executed in multiple trades at prices ranging from $96.235 to $96.93. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $96.235 to $96.92. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
